PubMed:32809870 / 0-588 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":554,"end":561},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":83},"obj":"Sentence"},{"id":"T2","span":{"begin":84,"end":162},"obj":"Sentence"},{"id":"T3","span":{"begin":163,"end":215},"obj":"Sentence"},{"id":"T4","span":{"begin":216,"end":418},"obj":"Sentence"},{"id":"T5","span":{"begin":419,"end":579},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":83},"obj":"Sentence"},{"id":"T2","span":{"begin":84,"end":162},"obj":"Sentence"},{"id":"T3","span":{"begin":163,"end":215},"obj":"Sentence"},{"id":"T4","span":{"begin":216,"end":418},"obj":"Sentence"},{"id":"T5","span":{"begin":419,"end":579},"obj":"Sentence"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":36,"end":44},"obj":"Disease"},{"id":"T2","span":{"begin":47,"end":56},"obj":"Disease"},{"id":"T3","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"T4","span":{"begin":239,"end":247},"obj":"Disease"},{"id":"T5","span":{"begin":271,"end":291},"obj":"Disease"},{"id":"T7","span":{"begin":282,"end":291},"obj":"Disease"},{"id":"T8","span":{"begin":379,"end":385},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0015265"},{"id":"A6","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0056821"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":134,"end":135},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":271,"end":281},"obj":"http://purl.obolibrary.org/obo/OBI_0000245"},{"id":"T3","span":{"begin":328,"end":338},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T4","span":{"begin":356,"end":357},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":505,"end":523},"obj":"Chemical"},{"id":"T2","span":{"begin":525,"end":538},"obj":"Chemical"},{"id":"T4","span":{"begin":534,"end":538},"obj":"Chemical"},{"id":"T5","span":{"begin":540,"end":548},"obj":"Chemical"},{"id":"T8","span":{"begin":554,"end":561},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_6888"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_22652"},{"id":"A3","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_29073"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_18385"},{"id":"A6","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_26948"},{"id":"A7","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_33283"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":342,"end":350},"obj":"http://purl.obolibrary.org/obo/GO_0050817"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":83},"obj":"Sentence"},{"id":"T2","span":{"begin":84,"end":162},"obj":"Sentence"},{"id":"T3","span":{"begin":163,"end":215},"obj":"Sentence"},{"id":"T4","span":{"begin":216,"end":418},"obj":"Sentence"},{"id":"T5","span":{"begin":419,"end":579},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1","span":{"begin":36,"end":56},"obj":"Disease"},{"id":"26","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"27","span":{"begin":239,"end":247},"obj":"Disease"},{"id":"28","span":{"begin":282,"end":291},"obj":"Disease"},{"id":"29","span":{"begin":365,"end":385},"obj":"Disease"},{"id":"30","span":{"begin":408,"end":417},"obj":"Disease"},{"id":"31","span":{"begin":505,"end":523},"obj":"Chemical"},{"id":"32","span":{"begin":525,"end":538},"obj":"Chemical"},{"id":"33","span":{"begin":540,"end":548},"obj":"Chemical"},{"id":"34","span":{"begin":554,"end":561},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"tao:has_database_id","subj":"1","obj":"MESH:C000657245"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"MESH:C000657245"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:C000657245"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:D011014"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:D017566"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:D000860"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D008775"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:D001205"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D013831"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D006493"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":282,"end":291},"obj":"Phenotype"},{"id":"T2","span":{"begin":306,"end":326},"obj":"Phenotype"},{"id":"T3","span":{"begin":408,"end":417},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002958"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0012418"}],"text":"MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.\nINTRODUCTION: COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in severe hypoxemia. The core treatment strategy to manage the pulmonary phase includes the combination of methylprednisolone, ascorbic acid, thiamine, and heparin (MATH+ protocol). The rati"}